Valuation (47%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 31.21 | N/A |
| PEG Ratio (TTM) | -25.59 | N/A |
| P/S Ratio (TTM) | 5.05 | N/A |
| P/B Ratio (TTM) | 1.76 | N/A |
| P/FCF Ratio (TTM) | 26.83 | N/A |
| Price to 5YR AVG Earnings Ratio | 19.63 | N/A |
| Price to 5YR AVG FCF Ratio | 15.42 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.65% | N/A |
| ROE (TTM) | 5.84% | N/A |
| Net Profit Margin (TTM) | 16.19% | N/A |
| ROIC 5YR AVG | 11.19% | N/A |
Growth (72%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 3.33% | 9.78% | -0.37% |
| Revenue | 6.48% | 13.16% | 8.42% |
| Net Income | 3.72% | 16.39% | 5.84% |
| Cash Flow | 57.02% | 55.39% | 30.97% |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.07 | N/A |
| Quick Ratio (TTM) | 0.07 | N/A |
| D/E Ratio (TTM) | 0.62 | N/A |
| Interest Coverage (TTM) | 0.72 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | 0.68 | N/A |
| Shares Outstanding Growth 5YR AVG | 5.87% | N/A |